| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other income (expense) | 1,852 | -6,520 | 2,922 | 3,554 |
| Net loss | -27,548 | -54,098 | -39,991 | -34,684 |
| Net unrealized gain (loss) on available-for-sale marketable securities, net of tax | 53 | -127 | -88 | 1,108 |
| Net comprehensive loss | -27,495 | -54,225 | -40,079 | -33,576 |
| Net loss per share, basic (in dollars per share) | -0.3 | -0.58 | -0.43 | -0.38 |
| Net loss per share, diluted (in dollars per share) | -0.3 | -0.58 | -0.43 | -0.38 |
| Weighted-average common shares outstanding, basic (in shares) | 93,293,099 | 93,028,698 | 92,679,493 | 90,455,900 |
| Weighted-average common shares outstanding, diluted (in shares) | 93,293,099 | 93,028,698 | 92,679,493 | 90,455,900 |
Caribou Biosciences, Inc. (CRBU)
Caribou Biosciences, Inc. (CRBU)